FibroGen
FGEN
$1.09
Share price
4.85%
Change (1 day)
-93.63%
Change (1 year)
Categories
FibroGen (FGEN) - Total debt
Total debt on the balance sheet as of December 2023 : $0.15 B
According to FibroGen's latest financial reports the company's total debt is $0.15 B. A company’s total debt is the sum of all current and non-current debts.
FibroGen - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | 69.71% |
| 2022-12-31 | $89.88 M | -9.86% |
| 2021-12-31 | $99.72 M | 150.79% |
| 2020-12-31 | $39.76 M | -21.89% |
| 2019-12-31 | $50.9 M | -47.61% |
| 2018-12-31 | $97.15 M | -0.62% |
| 2017-12-31 | $97.76 M | 0.42% |
| 2016-12-31 | $97.35 M | 0.32% |
| 2015-12-31 | $97.04 M | 0.23% |
| 2014-12-31 | $96.81 M | 0.01% |
| 2013-12-31 | $96.8 M | 3.84% |
| 2012-12-31 | $93.23 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $2.26 B | 1,382.81% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $39.22 M | -74.29% | 🇺🇸 USA |